Clinical efficacy of Lactobacillus reuteri-containing lozenges in the supportive therapy of generalized periodontitis stage III and IV, grade C: 1-year results of a double-blind randomized placebo-controlled pilot study.
Maria Gabriella GrusovinSimone BossiniStefano CalzaVeronica CappaGianluca GarzettiEleonara ScottiEnrico Felice GherloneMagda MensiPublished in: Clinical oral investigations (2019)
The use of L. reuteri probiotic lozenges could be considered as an adjunct in the maintenance therapy of GPIII-IVC patients.